search

Active clinical trials for "Tricuspid Valve Insufficiency"

Results 71-80 of 144

The Prospecive OBSERVational Munich Interventional MITRAl-Valve Registry

Mitral Valve RegurgitationMitral Valve Stenosis1 more

Prospective, single-center observational registry including all consecutive patients treated with transcatheter mitral or tricuspid valve therapy at the Deutsches Herzzentrum München, Germany.

Recruiting5 enrollment criteria

International Multisite Transcatheter Tricuspid Valve Therapies Registry

Severe Tricuspid Regurgitation

For a long time, tricuspid valve disease has been considered as less important than left-sided valvular heart disease. If treated in an advanced stage and simultaneously with other cardiac diseases, it is associated with significant morbidity and mortality. Hence, physicians tend to refer patients more aggressively to surgery (1). Transcatheter procedures are an attractive alternative in high-risk patients. The field of transcatheter tricuspid devices has rapidly advanced over the last few years (2). Limited knowledge is available regarding the epidemiologic and anatomical settings in which these therapies are preferentially applied. The main purpose of this registry is the collection of baseline clinical and anatomical data of the patients treated with transcatheter tricuspid valve therapies, and their outcomes, whenever feasible. Apart from more knowledge regarding the current status in this field, the results could also help the establishment of guidelines with respect to the choice of the transcatheter device selected and to understand which therapy can provide the better outcome in the different anatomies. Moreover, this study will provide important information about the epidemiology of severe tricuspid regurgitation, which is at the moment an undertreated disease.

Recruiting5 enrollment criteria

German Registry for Transcatheter Tricuspid Valve Interventions

Tricuspid RegurgitationTricuspid Valve Insufficiency1 more

Multicentre observational study of patients with severe tricuspid regurgitation and interventional treatment.

Recruiting4 enrollment criteria

Multiparametric Approach to Identify a CMR-based Tricuspid Regurgitation Classification

Tricuspid Regurgitation Congenital

The aims of this study are: to explore a novel 2D-Cardiovascular magnetic resonance (CMR) indirect method for tricuspid regurgitation (TR) quantification (ATRIAL method) relying on right atrium variables, and assess its agreement with the traditional indirect method (involving right ventricle variables) and the direct method (based on through-plane phase contrast (PC) sequences on the tricuspid valve); to assess the agreement of TR volume (RVol) and regurgitant fraction quantification from 2D-CMR methods with transthoracic echocardiography and 4DF-CMR methods; to assess the diagnostic performance of 2D-CMR in classifying TR, in terms of RVol and regurgitant fraction, with respect to echocardiographic transthoracic echocardiography grades.

Recruiting8 enrollment criteria

Prevalence Study of Cardiovascular Diseases in a Population ≥ 65 Years in Italy

Valvular Heart DiseaseMitral Valve Disease3 more

This registry is a large-scale epidemiological study (PREVASC) aimed at estimating the prevalence of symptomatic and asymptomatic valvular hear disease in men and women aged over 65 years randomly selected in Italy.

Recruiting4 enrollment criteria

Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System

Functional Tricuspid RegurgitationHeart Valve Diseases1 more

The primary objective of the study is to generate feasibility safety and performance data for the 4Tech TriCinch Coil System in symptomatic patients suffering from moderate to severe functional tricuspid regurgitation with annular dilatation. The TriCinch Coil System is a percutaneous catheter-based medical device for tricuspid valve repair.

Terminated39 enrollment criteria

An Observational Real-world Study Evaluating Severe Tricuspid Regurgitation Patients Treated With...

Tricuspid Valve Regurgitation

The bRIGHT EU PAS study is an observational real-world study evaluating severe tricuspid regurgitation patients treated with the Abbott TriClip™ device (bRIGHT EU Post-Approval Study).

Active4 enrollment criteria

Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study...

Tricuspid RegurgitationTricuspid Insufficiency

The purpose of the study is to assess the safety and the effectiveness of the Cardioband Tricuspid Reconstruction System.

Active11 enrollment criteria

Clinical Trial Evaluation of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System...

Tricuspid Regurgitation

The objective of the study is to generate safety and performance data for the 4Tech TriCinch Coil System in symptomatic patients suffering from significant functional tricuspid regurgitation with annular dilatation. The TriCinch Coil System is a percutaneous catheter-based medical device for tricuspid valve repair.

Terminated39 enrollment criteria

Prevalence and Prognostic Relevance of Tricuspid Regurgitation in Different Heart Failure Entities...

Tricuspid RegurgitationHeart Failure

The present study includes patients with tricuspid regurgitation and heart failure diagnosed with echocardiography. The aim is to evaluate the physical performance of patients with tricuspid regurgitation and heart failure, to observe the course of the diseases and to allow a better understanding of new therapy options.

Active5 enrollment criteria
1...789...15

Need Help? Contact our team!


We'll reach out to this number within 24 hrs